Oxnard GR - Search Results

1

Rociletinib in EGFR-mutated non-small-cell lung cancer.

Sequist LV, Soria JC, Goldman JW, Wakelee HA, Gadgeel SM, Varga A, Papadimitrakopoulou V, Solomon BJ, Oxnard GR, Dziadziuszko R, Aisner DL, Doebele RC, Galasso C, Garon EB, Heist RS, Logan J, Neal JW, Mendenhall MA, Nichols S, Piotrowska Z, Wozniak AJ, Raponi M, Karlovich CA, Jaw-Tsai S, Isaacson J, Despain D, Matheny SL, Rolfe L, Allen AR, Camidge DR. Sequist LV, et al. Among authors: oxnard gr. N Engl J Med. 2015 Apr 30;372(18):1700-9. doi: 10.1056/NEJMoa1413654. N Engl J Med. 2015. PMID: 25923550 Free article. Clinical Trial.

2

Non-small cell lung cancer in octogenarians: treatment practices and preferences.

Oxnard GR, Fidias P, Muzikansky A, Sequist LV. Oxnard GR, et al. J Thorac Oncol. 2007 Nov;2(11):1029-35. doi: 10.1097/JTO.0b013e318158d4a2. J Thorac Oncol. 2007. PMID: 17975495 Free article.

3

New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer.

Oxnard GR, Arcila ME, Chmielecki J, Ladanyi M, Miller VA, Pao W. Oxnard GR, et al. Clin Cancer Res. 2011 Sep 1;17(17):5530-7. doi: 10.1158/1078-0432.CCR-10-2571. Epub 2011 Jul 20. Clin Cancer Res. 2011. PMID: 21775534 Free PMC article. Review.

4

"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.

Grommes C, Oxnard GR, Kris MG, Miller VA, Pao W, Holodny AI, Clarke JL, Lassman AB. Grommes C, et al. Among authors: oxnard gr. Neuro Oncol. 2011 Dec;13(12):1364-9. doi: 10.1093/neuonc/nor121. Epub 2011 Aug 24. Neuro Oncol. 2011. PMID: 21865399 Free PMC article.

5

Strategies for overcoming acquired resistance to epidermal growth factor receptor: targeted therapies in lung cancer.

Oxnard GR. Oxnard GR. Arch Pathol Lab Med. 2012 Oct;136(10):1205-9. doi: 10.5858/arpa.2012-0254-RA. Arch Pathol Lab Med. 2012. PMID: 23020725 Free article. Review.

6

Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.

Oxnard GR, Lo PC, Nishino M, Dahlberg SE, Lindeman NI, Butaney M, Jackman DM, Johnson BE, Jänne PA. Oxnard GR, et al. J Thorac Oncol. 2013 Feb;8(2):179-84. doi: 10.1097/JTO.0b013e3182779d18. J Thorac Oncol. 2013. PMID: 23328547 Free PMC article.

7

New targetable oncogenes in non-small-cell lung cancer.

Oxnard GR, Binder A, Jänne PA. Oxnard GR, et al. J Clin Oncol. 2013 Mar 10;31(8):1097-104. doi: 10.1200/JCO.2012.42.9829. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401445 Free PMC article. Review.

8

Power in numbers: meta-analysis to identify inhibitor-sensitive tumor genotypes.

Oxnard GR, Jänne PA. Oxnard GR, et al. Clin Cancer Res. 2013 Apr 1;19(7):1634-6. doi: 10.1158/1078-0432.CCR-13-0169. Epub 2013 Feb 12. Clin Cancer Res. 2013. PMID: 23403632 Free PMC article.

9

Acquired resistance to targeted therapies in advanced non-small cell lung cancer: new strategies and new agents.

West H, Oxnard GR, Doebele RC. West H, et al. Among authors: oxnard gr. Am Soc Clin Oncol Educ Book. 2013:10.1200/EdBook_AM.2013.33.e272. doi: 10.14694/EdBook_AM.2013.33.e272. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714521 Free PMC article. Review.

10

Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors.

Goldberg SB, Oxnard GR, Digumarthy S, Muzikansky A, Jackman DM, Lennes IT, Sequist LV. Goldberg SB, et al. Among authors: oxnard gr. Oncologist. 2013;18(11):1214-20. doi: 10.1634/theoncologist.2013-0168. Epub 2013 Sep 26. Oncologist. 2013. PMID: 24072220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters